Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

Spire Healthcare to publish 2026 interim results on 9 September

Spire Healthcare will announce interim results for the six months ended 30 June 2026 on 9 September 2026...

July 21, 2026

EDX Medical launches BC95 bowel cancer testing service in the UK

July 21, 2026

Genflow Biosciences advances a focused gene therapy pipeline for healthy ageing

Genflow Biosciences is building a focused SIRT6 gene therapy pipeline across human health, veterinary medicine and skin-related applications...

July 20, 2026

GSK filing accepted by EMA for Bexsero booster label update

GSK says the EMA has accepted a submission to update Bexsero’s label to include a single-dose booster for older previously vaccinated individuals...

July 20, 2026

SIRT6 positions Genflow Biosciences in a high-value area of longevity research

Genflow Biosciences is targeting SIRT6 as a potential route to improve DNA repair, metabolic control and healthier ageing...

July 17, 2026

Biotech Growth Trust portfolio company AtaiBeckley to be acquired by Eli Lilly

Eli Lilly’s proposed acquisition of AtaiBeckley values the biotechnology company at up to $3.8 billion, including contingent milestone payments. The transaction is the latest in a series of portfolio acquisitions..

July 17, 2026

EDX Medical Group Targets More Than £2 Million From New Employee Health Screening Service (video)

Chief Scientific Officer Sir Chris Evans explains how its on-site testing model, multi-biomarker panels and personalised reports could help employers identify health risks earlier while reducing disruption and absenteeism...

July 16, 2026

EDX Medical builds scale through Scottish Prostate Cancer Testing programme

EDX Medical is expanding its role in a 25,000-participant Scottish programme testing a more targeted approach to prostate cancer detection...

July 15, 2026

Convatec names NED and outlines CFO transition

Convatec has outlined finance leadership changes, appointed Tobias Hestler as a Non-Executive Director and reaffirmed its 2026 expectations...

July 15, 2026

Cizzle Biotechnology reports US accreditation and patent progress in H1 2026

July 15, 2026

Genus expects FY26 profit ahead of consensus after stronger second half

Genus Plc says second-half trading improved, with stronger PIC and ABS performance, and now expects FY26 results moderately ahead of consensus...

July 14, 2026

Biotech Growth Trust gains 19.2% in June, outperforms benchmark

The Biotech Growth Trust delivered a 19.2% NAV return in June, ahead of the NASDAQ Biotechnology Index’s 11.4% gain, supported by positive clinical, regulatory and M&A developments across the sector...

July 14, 2026

Spire Healthcare names Debbie White as Chair-designate ahead of Sir Ian Cheshire’s departure

Spire Healthcare has announced that Sir Ian Cheshire will step down as Chair by 30 September 2026 and Debbie White will succeed him...

July 14, 2026

Astrazeneca secures global rights to Zegfrovy in EGFR-mutated lung cancer

Astrazeneca Plc has agreed an exclusive licence with Dizal Pharmaceutical for Zegfrovy, adding a novel oral EGFR inhibitor to its oncology portfolio...

July 14, 2026

Genflow Biosciences reports continued SIRT6 progress in first half of 2026

Genflow Biosciences reported positive interim and three-month follow-up results from its SLAB canine trial, expanded animal health partnerships, secured a fully funded LNP collaboration with Acuitas Therapeutics and strengthened its..

July 13, 2026

GSK reports positive interim AZUR-1 results for Jemperli in rectal cancer

GSK has reported positive interim AZUR-1 results for Jemperli in dMMR/MSI-H locally advanced rectal cancer, with the study meeting its primary objective...

July 13, 2026

AstraZeneca and Ionis’ Wainua misses Phase III ATTR-CM trial endpoint

The CARDIO-TTRansform Phase III trial1 for AstraZeneca and Ionis' Wainua (eplontersen) in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) did not meet the primary efficacy.....

July 9, 2026

Biotech Growth Trust: The biotech rebound powered by innovation, valuations and pharma’s patent cliff

Biotech Growth Trust gives UK investors access to a global biotech sector where Geoffrey Hsu sees a rare combination of scientific innovation, attractive valuations, supportive regulation and renewed M&A momentum...

July 8, 2026

Verici Dx strengthens the case for RNA-based kidney transplant diagnostics

Verici Dx is using multicentre clinical data to support RNA-based diagnostics for kidney transplant risk assessment...

July 8, 2026

Gene research sharpens the case for targeted biotechnology

Genflow’s focus on SIRT6 highlights how gene science is shaping more targeted approaches to ageing and age-related disease...

July 7, 2026

News and Interview Alerts

Company Presentations

Q&As

CMC Markets targets multi-asset expansion through retail innovation (LON:CMCX)

29 July 2026

RM plc CFO Simon Goodwin discusses Assessment growth, RM Ava and full-year outlook

24 July 2026

James Cropper delivers strategy progress as profitability improves (LON:CRPR)

24 July 2026

Professor Sir Chris Evans outlines EDX Medical’s new workplace health screening service

24 July 2026

Alien Metals’ Bruce Garlick on the Georgina Basin acquisition and growth strategy

14 July 2026

Hardman & Co

Arbuthnot Banking Group Plc 1H’26: accelerating franchise growth

4 August 2026

Real Estate Credit Investments maintains dividend as credit remains resilient

3 August 2026

Real Estate Credit Investments (RECI) FY’26 results: High yield, clear path to dividend cover

13 July 2026

Cavendish plc: Solid performance in still tough markets

30 June 2026

Cavendish plc delivers solid performance in tough markets

24 June 2026

Green News

Quadrise extends Morocco representation agreement

31 July 2026

Ferro-Alloy Resources appoints new CEO and advances US funding plans

31 July 2026

Quadrise and Licella advance low-carbon marine fuel testing

30 July 2026

Drax delivers solid first-half performance and advances growth plans

30 July 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

Oriole Resources Mbe Gold Resource Jumps to 1.66 Million Ounces as District-Scale Potential Builds (video)

CMC Markets: Why Simpler Technology and Global Reach Could Drive Its Next Retail Growth Phase (video)

RM Plc Assessment Pipeline Doubles as RM Ava Opens New Growth Markets (video)

James Cropper plc Lifts EBITDA 33% as Debt Falls Below One Times Earnings (video)

EDX Medical Group Targets More Than £2 Million From New Employee Health Screening Service (video)

Alien Metals’ Georgina Basin Move Opens a New Copper-Uranium Growth Front (video)

BrokerTalk

Fidelity Emerging Markets outperforms as technology exposure rises highlighted in latest research (LON:FEML)

30 July 2026

Hardide Plc FY26 EPS Forecast Raised 33% as Cavendish Lifts Target Price

22 July 2026

Pharos Energy reports high production, strong cash position and further Vietnam drilling progress, Auctus Advisors

20 July 2026

Avingtrans Raises £21 Million to Expand Its US Nuclear Opportunity, Cavendish

20 July 2026

Valeura Energy Builds Cash Position as Bussabong Catalyst Approaches, Auctus Advisors

10 July 2026

Funds

JEDT European investment fund buoyed by financial sector strength

4 August 2026

Fidelity Emerging Markets outperforms as technology exposure rises highlighted in latest research (LON:FEML)

30 July 2026

Geiger Counter posts strong one-year growth as uranium outlook strengthens

30 July 2026

Biotech Growth Trust notes $2.2 billion acquisition of Forte Biosciences

28 July 2026

Ruffer Investment Company delivers positive 2026 returns

24 July 2026

View all Funds, Market Insights and news >>

FTSE 100 News

Fresnillo first-half profit triples as precious metals prices lift revenue

4 August 2026

BP posts $5.7bn underlying profit and raises dividend in second quarter

4 August 2026

HSBC first-half profit rises 23% to $19.5bn

4 August 2026

Halma completes sale of NovaBone for $60m

4 August 2026

UK Broker Ratings

Sirius Real Estate (SRE.L): Investor Outlook Reveals 23.81% Potential Upside Amid Strong Buy Ratings

6 August 2026

Edinburgh Investment Trust PLC (EDIN.L) Stock Analysis: Navigating a Steady Course with Strong Buy Sentiment

6 August 2026

SSP Group PLC (SSPG.L): Investor Insights and Growth Potential Amid a 10.45% Upside

6 August 2026

Syncona Limited (SYNC.L): Analyst Consensus Signals a Striking 90.57% Upside Potential

6 August 2026

Supermarket Income REIT (SUPR.L) Stock Analysis: A High-Yield Opportunity in the Retail Real Estate Sector

6 August 2026

Health

Spire Healthcare to publish 2026 interim results on 9 September

Spire Healthcare will announce interim results for the six months ended 30 June 2026 on 9 September 2026...

July 21, 2026

EDX Medical launches BC95 bowel cancer testing service in the UK

EDX Medical Group has launched full UK availability of its BC95 bowel cancer biomarker testing service, combining early detection, hereditary risk analysis and a faecal haemoglobin reference test. The service reports sensitivity above 95% across all cancer stages and is designed to improve early diagnosis of colorectal cancer, which affects more than 46,000 people annually in the UK...

July 21, 2026

Genflow Biosciences advances a focused gene therapy pipeline for healthy ageing

Genflow Biosciences is building a focused SIRT6 gene therapy pipeline across human health, veterinary medicine and skin-related applications...

July 20, 2026

GSK filing accepted by EMA for Bexsero booster label update

GSK says the EMA has accepted a submission to update Bexsero’s label to include a single-dose booster for older previously vaccinated individuals...

July 20, 2026

SIRT6 positions Genflow Biosciences in a high-value area of longevity research

Genflow Biosciences is targeting SIRT6 as a potential route to improve DNA repair, metabolic control and healthier ageing...

July 17, 2026

Biotech Growth Trust portfolio company AtaiBeckley to be acquired by Eli Lilly

July 17, 2026

EDX Medical Group Targets More Than £2 Million From New Employee Health Screening Service (video)

July 16, 2026

EDX Medical builds scale through Scottish Prostate Cancer Testing programme

EDX Medical is expanding its role in a 25,000-participant Scottish programme testing a more targeted approach to prostate cancer detection...

July 15, 2026

Convatec names NED and outlines CFO transition

Convatec has outlined finance leadership changes, appointed Tobias Hestler as a Non-Executive Director and reaffirmed its 2026 expectations...

July 15, 2026

Cizzle Biotechnology reports US accreditation and patent progress in H1 2026

Cizzle Biotechnology entered its commercialisation phase during the first half of 2026 after securing CLIA accreditation for its CIZ1B early lung cancer test in the U.S. The company also strengthened its North American patent position and increased guaranteed minimum royalty receipts to approximately US$5.9 million...

July 15, 2026

Genus expects FY26 profit ahead of consensus after stronger second half

Genus Plc says second-half trading improved, with stronger PIC and ABS performance, and now expects FY26 results moderately ahead of consensus...

July 14, 2026

Biotech Growth Trust gains 19.2% in June, outperforms benchmark

July 14, 2026

Spire Healthcare names Debbie White as Chair-designate ahead of Sir Ian Cheshire’s departure

Spire Healthcare has announced that Sir Ian Cheshire will step down as Chair by 30 September 2026 and Debbie White will succeed him...

July 14, 2026

Astrazeneca secures global rights to Zegfrovy in EGFR-mutated lung cancer

Astrazeneca Plc has agreed an exclusive licence with Dizal Pharmaceutical for Zegfrovy, adding a novel oral EGFR inhibitor to its oncology portfolio...

July 14, 2026

Genflow Biosciences reports continued SIRT6 progress in first half of 2026

July 13, 2026

GSK reports positive interim AZUR-1 results for Jemperli in rectal cancer

GSK has reported positive interim AZUR-1 results for Jemperli in dMMR/MSI-H locally advanced rectal cancer, with the study meeting its primary objective...

July 13, 2026

AstraZeneca and Ionis’ Wainua misses Phase III ATTR-CM trial endpoint

The CARDIO-TTRansform Phase III trial1 for AstraZeneca and Ionis' Wainua (eplontersen) in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) did not meet the primary efficacy.....